Home > Insider Trading > Filing (0001209191-18-045591)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1406338	Amit Sachdev	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210	Evp, Cro	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2018-08-02	2,155	$91.05	48,817	No	4	M	Direct
Common Stock	Disposition	2018-08-02	700	$175.06	48,117	No	4	S	Direct
Common Stock	Disposition	2018-08-02	400	$175.88	47,717	No	4	S	Direct
Common Stock	Disposition	2018-08-02	400	$176.95	47,317	No	4	S	Direct
Common Stock	Disposition	2018-08-02	355	$178.49	46,962	No	4	S	Direct
Common Stock	Disposition	2018-08-02	300	$179.38	46,662	No	4	S	Direct
Common Stock	Acquisiton	2018-08-03	1,942	$86.52	48,604	No	4	M	Direct
Common Stock	Disposition	2018-08-03	1,142	$174.50	47,462	No	4	S	Direct
Common Stock	Disposition	2018-08-03	700	$175.86	46,762	No	4	S	Direct
Common Stock	Disposition	2018-08-03	100	$176.69	46,662	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2018-08-02	2,155	$0.00	2,155	$91.05
Common Stock	Stock Option (Right to Buy)	Disposition	2018-08-03	1,942	$0.00	1,942	$86.52

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
12,932		2026-02-01	No	4	M	Direct
19,416		2027-02-02	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	882	Indirect	401(k)
Common Stock	12,215	Indirect	Held in Trust

Footnotes

Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $175.06 (range $174.47 to $175.43).
Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $175.88 (range $175.52 to $176.10).
Open market sales reported on this line occurred at a weighted average price of $176.95 (range $176.62 to $177.21).
Open market sales reported on this line occurred at a weighted average price of $178.49 (range $178.09 to $178.77).
Open market sales reported on this line occurred at a weighted average price of $179.38 (range $179.17 to $179.49).
Open market sales reported on this line occurred at a weighted average price of $174.50 (range $174.17 to $175.07).
Open market sales reported on this line occurred at a weighted average price of $175.86 (range $175.57 to $176.30).
The option vests in 16 quarterly installments from 2/2/2016.
The option vests in 16 quarterly installments from 2/3/2017.